Micro-immunotherapy & Epstein-Barr virus infections

More and more people are suffering from persistent and largely unexplained symptoms (Fig. 1). The real causes are often undetected. Do you also have a wide range of similar symptoms? Have you or your doctor ever considered the potential impact of the Epstein-Barr virus (EBV)? Clinical experience of practitioners of micro-immunotherapy has shown that these manifestations are indicative of a reactivation of this virus. Therefore, in order to avoid multiple potential misdiagnoses, it is convenient to rule out diagnostically an EBV burden in these cases.

Sore throat and/or swollen cervical lymph nodes

Chronic malaise

Migratory joint and muscle pain

Severe fatigue

Unexplained temperature spikes

Fig. 1: Symptoms indicative of EBV reactivation

Furthermore, this virus, which is the most common cause of glandular fever (also known as mononucleosis), has also been associated with a wide range of different diseases (Fig. 2).

Glandular fever (mononucleosis)

Fibromyalgia and other pain disorders

Recurrent infections

Autoimmune diseases (including multiple sclerosis, Hashimoto, Lupus)

Chronic fatigue syndrome

Cancer (including Burkitt lymphoma, Hodgkin’s disease)

Fig. 2: Association between EBV and various diseases (a selection)

Hence, it is important to detect EBV and treat it if a viral burden is confirmed, thereby positively influencing the course of the illness, and paving the way towards health. Since the immune system plays an important role in controlling the EBV infection, immunomodulatory treatments like micro-immunotherapy may be of great help. The formula used to treat EBV infections is aimed at inhibiting virus replication and/or infection of other cells via a specific combination of immunomodulatory substances (including cytokines) and nucleic acids in low doses, thereby supporting the function of the immune system at the same time.

Learn more about the EBV infection/reactivation and the approach of micro-immunotherapy in these cases.